☰

Debarshi Roy, Ph.D. - Publications

Affiliations: 
2012 Biological Sciences University of Texas at El Paso, El Paso, TX, United States 
Area:
Biochemistry, Cell Biology, Oncology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bhowmick S, Biswas T, Ahmed M, Roy D, Mondal S. Caveolin-1 and lipids: Association and their dualism in oncogenic regulation. Biochimica Et Biophysica Acta. Reviews On Cancer. 1878: 189002. PMID 37848094 DOI: 10.1016/j.bbcan.2023.189002  0.363
2023 Pal S, Bhowmick S, Sharma A, Sierra-Fonseca JA, Mondal S, Afolabi F, Roy D. Lymphatic vasculature in ovarian cancer. Biochimica Et Biophysica Acta. Reviews On Cancer. 188950. PMID 37419192 DOI: 10.1016/j.bbcan.2023.188950  0.326
2022 Sengupta B, Biswas P, Roy D, Lovett J, Simington L, Fry DR, Travis K. Anticancer Properties of Kaempferol on Cellular Signaling Pathways. Current Topics in Medicinal Chemistry. PMID 36082856 DOI: 10.2174/1568026622666220907112822  0.391
2022 Roy D, Jenkins B, Ali A, Herschmann JR, Harris M, Zamadar M, Simington L, Odunuga O, Adhikari P, Pradhan P, Sarkar S, Pattabiram M, Sengupta B. Multi-component redox system for selective and potent antineoplastic activity towards ovarian cancer cells. Biochemical and Biophysical Research Communications. 592: 38-43. PMID 35026603 DOI: 10.1016/j.bbrc.2022.01.007  0.338
2021 Ray U, Jung DB, Jin L, Xiao Y, Dasari S, Sarkar Bhattacharya S, Thirusangu P, Staub JK, Roy D, Roy B, Weroha SJ, Hou X, Purcell JW, Bakkum-Gamez JN, Kaufmann SH, et al. Targeting LRRC15 inhibits metastatic dissemination of ovarian cancer. Cancer Research. PMID 34654724 DOI: 10.1158/0008-5472.CAN-21-0622  0.336
2021 Ray U, Roy D, Jin L, Thirusangu P, Staub J, Xiao Y, Kalogera E, Wahner Hendrickson AE, Cullen GD, Goergen K, Oberg AL, Shridhar V. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization. Journal of Experimental & Clinical Cancer Research : Cr. 40: 182. PMID 34082797 DOI: 10.1186/s13046-021-01985-9  0.332
2020 Hoffmann R, Sarkar Bhattacharya S, Roy D, Winterhoff B, Schmidmaier R, Dredge K, Hammond E, Shridhar V. Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer. Biochemical Pharmacology. 114003. PMID 32360360 DOI: 10.1016/J.Bcp.2020.114003  0.431
2020 Adhikari P, Hasan M, Shridhar V, Roy D, Pradhan P. Nanoscale structural alterations in cancer cells to assess anti-cancerous drug effectiveness in ovarian cancer treatment using TEM imaging. Physical Biology. PMID 31931492 DOI: 10.1088/1478-3975/Ab6Abb  0.438
2019 Sarkar Bhattacharya S, Thirusangu P, Jin L, Roy D, Jung D, Xiao Y, Staub J, Roy B, Molina JR, Shridhar V. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses. Cell Death & Disease. 10: 725. PMID 31562297 DOI: 10.1038/S41419-019-1916-3  0.452
2019 Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, et al. Genes associated with bowel metastases in ovarian cancer. Gynecologic Oncology. PMID 31204077 DOI: 10.1016/J.Ygyno.2019.06.010  0.357
2018 Chatterjee A, Roy D, Guevara P, Pal R, Naryan M, Roychowdhury S, Das S. Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors. Clinical Cancer Drugs. 5: 28-41. PMID 30443489 DOI: 10.2174/2212697X05666180418145601  0.67
2018 Mondal S, Roy D, Sarkar Bhattacharya S, Jin L, Jung D, Zhang S, Kalogera E, Staub J, Wang Y, Xuyang W, Khurana A, Chien J, Telang S, Chesney J, Tapolsky G, et al. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. International Journal of Cancer. PMID 30226266 DOI: 10.1002/Ijc.31868  0.524
2018 Jung D, Khurana A, Roy D, Kalogera E, Bakkum-Gamez J, Chien J, Shridhar V. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer. Scientific Reports. 8: 2487. PMID 29410485 DOI: 10.1038/S41598-018-20531-W  0.348
2018 Kalogera E, Roy D, Bakkum-Gamez JN, Cliby BA, Dowdy SC, Shridhar V. Atorvastatin antagonizes carboplatin, synergizes with the glycolytic inhibitor pfk-158 and induces lipid laden multilamellar bodies in ovarian cancer Gynecologic Oncology. 149: 632-633. DOI: 10.1016/J.Ygyno.2018.03.041  0.429
2017 Kalogera E, Roy D, Khurana A, Mondal S, Weaver AL, He X, Dowdy SC, Shridhar V. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug. Gynecologic Oncology. PMID 28545688 DOI: 10.1016/J.Ygyno.2017.04.022  0.407
2017 Roy D, Mondal S, Khurana A, Jung DB, Hoffmann R, He X, Kalogera E, Dierks T, Hammond E, Dredge K, Shridhar V. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer. Scientific Reports. 7: 41977. PMID 28169314 DOI: 10.1038/Srep41977  0.524
2016 Roy D, Khurana A, Kalogera E, Wen X, Mondal S, Shridhar V. Abstract B74: Can we repurpose anti-malarial drug quinacrine to treat ovarian cancer? Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B74  0.443
2016 Kalogera E, Roy D, Khurana A, Mondal S, He X, Dowdy SC, Shridhar V. Abstract 261: Quinacrine in endometrial cancer: repurposing an old antimalarial drug Cancer Research. 76: 261-261. DOI: 10.1158/1538-7445.Am2016-261  0.358
2015 Khurana A, Roy D, Kalogera E, Mondal S, Wen X, He X, Dowdy S, Shridhar V. Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth. Oncotarget. PMID 26497553 DOI: 10.18632/Oncotarget.5632  0.44
2015 Mondal S, Roy D, Camacho-Pereira J, Khurana A, Chini E, Yang L, Baddour J, Stilles K, Padmabandu S, Leung S, Kalloger S, Gilks B, Lowe V, Dierks T, Hammond E, et al. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget. 6: 33705-19. PMID 26378042 DOI: 10.18632/Oncotarget.5605  0.426
2015 Winterhoff B, Freyer L, Hammond E, Giri S, Mondal S, Roy D, Teoman A, Mullany SA, Hoffmann R, von Bismarck A, Chien J, Block MS, Millward M, Bampton D, Dredge K, et al. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. European Journal of Cancer (Oxford, England : 1990). 51: 879-92. PMID 25754234 DOI: 10.1016/J.Ejca.2015.02.007  0.375
2015 Mondal S, Roy D, Kalogera E, Khurana A, Tapolsky GH, Telang S, Chesney J, Shridhar V. Abstract 2706: Inhibition of PFKFB3/glycolysis overcomes chemoresistance in ovarian cancers Cancer Research. 75: 2706-2706. DOI: 10.1158/1538-7445.Am2015-2706  0.466
2015 Roy D, Mondal S, Khurana A, He X, Hammond E, Dredge K, Shridhar V. Abstract 1135: Loss of HSulf-1 promotes defective autophagy and increased lipid droplet biogenesis in ovarian cancer Cancer Research. 75: 1135-1135. DOI: 10.1158/1538-7445.Am2015-1135  0.535
2014 Roy D, Mondal S, Wang C, He X, Khurana A, Giri S, Hoffmann R, Jung DB, Kim SH, Chini EN, Periera JC, Folmes CD, Mariani A, Dowdy SC, Bakkum-Gamez JN, et al. Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer & Metabolism. 2: 24. PMID 26075069 DOI: 10.1186/2049-3002-2-24  0.313
2014 Roy D, Mondal S, Wang C, He X, Khurana A, Giri S, Hoffmann R, Jung DB, Kim SH, Chini EN, Periera JC, Folmes CD, Mariani A, Dowdy SC, Bakkum-Gamez JN, et al. Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer & Metabolism. 2: 13. PMID 25225614 DOI: 10.1186/2049-3002-2-13  0.449
2014 He X, Khurana A, Roy D, Kaufmann S, Shridhar V. Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 135: 1783-9. PMID 24596063 DOI: 10.1002/Ijc.28818  0.421
2014 Roy D, Kabiraj P, Pal R. EF24 prevents rotenone-induced estrogenic status alteration in breast cancer. Cell Biology International. 38: 511-9. PMID 24375813 DOI: 10.1002/Cbin.10224  0.329
2014 Mondal S, Roy D, Pereira JC, Chini EN, Shridhar V. Abstract 3360: Loss of sulf-1 reprograms energy metabolism in ovarian cancer Cancer Research. 74: 3360-3360. DOI: 10.1158/1538-7445.Am2014-3360  0.474
2014 Roy D, He X, Khurana A, Mondal S, Jung D, Kim S, Dierks T, Folmes C, Terzic A, Shridhar V. Abstract 2439: HSulf-1 loss in ovarian cancer cells induces lipid droplet biogenesis Cancer Research. 74: 2439-2439. DOI: 10.1158/1538-7445.Am2014-2439  0.537
2013 Mendez TL, De Chatterjee A, Duarte TT, Gazos-Lopes F, Robles-Martinez L, Roy D, Sun J, Maldonado RA, Roychowdhury S, Almeida IC, Das S. Glucosylceramide transferase activity is critical for encystation and viable cyst production by an intestinal protozoan, Giardia lamblia. The Journal of Biological Chemistry. 288: 16747-60. PMID 23589290 DOI: 10.1074/Jbc.M112.438416  0.637
2011 Yichoy M, Duarte TT, De Chatterjee A, Mendez TL, Aguilera KY, Roy D, Roychowdhury S, Aley SB, Das S. Lipid metabolism in Giardia: a post-genomic perspective. Parasitology. 138: 267-78. PMID 20880419 DOI: 10.1017/S0031182010001277  0.636
2011 Roy D, De CA, Pal R, Roychowdhury S, Das S. P4-05-04: Arachidonic Acid-Induced Elevated Expression of 5-Lipoxygenase Is Linked to Metastatic Migration of Breast Cancer Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-05-04  0.672
Show low-probability matches.